<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.07600.018</object-id><label>Table 2.</label><caption><p>Precision and constraint statistics of MCM modeling, including conformationally heterogeneous states</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.07600.018">http://dx.doi.org/10.7554/eLife.07600.018</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>RNA</th><th>Length</th><th>Number of models</th><th>Size of largest cluster</th><th>RMSD to crystal, cluster center (&#197;) (accuracy)</th><th>In situ RMSD estimate (&#197;) (precision)</th><th>Total constraints</th><th>Percent strong constraints satisfied,<xref ref-type="table-fn" rid="tblfn5">*</xref> cluster center</th><th>Percent strong constraints satisfied, crystal</th><th>Percent weak constraints satisfied, cluster center</th><th>Percent weak constraints satisfied, crystal</th></tr></thead><tbody><tr><td><italic>Tetrahymena</italic> ribozyme P4&#8211;P6 domain</td><td>158</td><td>61,115</td><td>48</td><td>8.6</td><td>16.5</td><td>35</td><td>65.4</td><td>69.2</td><td>55.6</td><td>44.4</td></tr><tr><td><italic>V. cholerae</italic> cyclic-di-GMP riboswitch aptamer, bound</td><td>89</td><td>15,632</td><td>10</td><td>7.6</td><td>6.8</td><td>19</td><td>100.0</td><td>100.0</td><td>100.0</td><td>75.0</td></tr><tr><td><italic>V. cholerae</italic> cyclic-di-GMP riboswitch aptamer, unbound<xref ref-type="table-fn" rid="tblfn6">&#8224;</xref></td><td>89</td><td>26,421</td><td>5</td><td>(26.0)<xref ref-type="table-fn" rid="tblfn7">&#8225;</xref></td><td>9.8</td><td>14</td><td>100.0</td><td>83.3</td><td>75.0</td><td>37.5</td></tr><tr><td><italic>F. nucleatum</italic> double glycine riboswitch ligand-binding domain, bound</td><td>159</td><td>16,506</td><td>14</td><td>7.9</td><td>10.0</td><td>31</td><td>95.8</td><td>100.0</td><td>57.1</td><td>42.9</td></tr><tr><td><italic>F. nucleatum</italic> double glycine riboswitch ligand-binding domain, unbound<xref ref-type="table-fn" rid="tblfn6">&#8224;</xref></td><td>159</td><td>15,771</td><td>12</td><td>(25.4)<xref ref-type="table-fn" rid="tblfn7">&#8225;</xref></td><td>26.7</td><td>12</td><td>N/A<xref ref-type="table-fn" rid="tblfn8">&#167;</xref></td><td>N/A<xref ref-type="table-fn" rid="tblfn8">&#167;</xref></td><td>58.3</td><td>83.3</td></tr><tr><td><italic>F. nucleatum</italic> double glycine riboswitch ligand-binding domain with leader, bound</td><td>167</td><td>23,153</td><td>19</td><td>11.8</td><td>10.6</td><td>49</td><td>89.5</td><td>84.2</td><td>83.3</td><td>83.3</td></tr><tr><td><italic>F. nucleatum</italic> double glycine riboswitch ligand-binding domain with leader, unbound<xref ref-type="table-fn" rid="tblfn6">&#8224;</xref></td><td>167</td><td>18,096</td><td>15</td><td>(15.6)<xref ref-type="table-fn" rid="tblfn7">&#8225;</xref></td><td>14.7</td><td>34</td><td>77.8</td><td>33.3</td><td>64.0</td><td>68.0</td></tr><tr><td><italic>S. thermophilum</italic> adenosylcobalamin riboswitch aptamer, bound<xref ref-type="table-fn" rid="tblfn9">#</xref></td><td>168</td><td>14,219</td><td>12</td><td>11.9</td><td>13.9</td><td>38</td><td>84.0</td><td>76.0</td><td>84.6</td><td>69.2</td></tr><tr><td><italic>S. thermophilum</italic> adenosylcobalamin riboswitch aptamer, unbound<xref ref-type="table-fn" rid="tblfn6">&#8224;</xref>,<xref ref-type="table-fn" rid="tblfn9">#</xref></td><td>168</td><td>11,980</td><td>10</td><td>(17.3)<xref ref-type="table-fn" rid="tblfn7">&#8225;</xref></td><td>19.7</td><td>33</td><td>83.3</td><td>94.4</td><td>73.3</td><td>73.3</td></tr><tr><td>Class I ligase (unknotted)</td><td>127</td><td>17,881</td><td>7</td><td>14.5</td><td>11.6</td><td>24</td><td>86.7</td><td>53.3</td><td>22.2</td><td>77.8</td></tr><tr><td>Class I ligase (unknotted), core domain<xref ref-type="table-fn" rid="tblfn10">&#182;</xref></td><td>87</td><td>17,881</td><td>7</td><td>11.1</td><td>12.0</td><td>18</td><td>91.7</td><td>58.3</td><td>33.3</td><td>50.0</td></tr><tr><td>Class I ligase (knotted)</td><td>127</td><td>17,881</td><td>14</td><td>16.1</td><td>11.6</td><td>24</td><td>86.7</td><td>53.3</td><td>55.6</td><td>77.8</td></tr><tr><td><italic>D. iridis</italic> lariat capping ribozyme</td><td>188</td><td>19,741</td><td>16</td><td>8.2</td><td>5.7</td><td>32</td><td>90.0</td><td>70.0</td><td>54.5</td><td>54.5</td></tr><tr><td><italic>D. iridis</italic> lariat capping ribozyme, RNA-puzzles submission model #1 (2012)</td><td>188</td><td>&#8211;</td><td>&#8211;</td><td>9.6</td><td>&#8211;</td><td>&#8211;</td><td>60.0</td><td>70.0</td><td>59.1</td><td>54.5</td></tr><tr><td><italic>D. iridis</italic> lariat capping ribozyme, MCM refined regions<xref ref-type="table-fn" rid="tblfn10">&#182;</xref></td><td>69</td><td>19,741</td><td>16</td><td>11.2</td><td>10.5</td><td>32</td><td>87.5</td><td>62.5</td><td>46.2</td><td>38.5</td></tr><tr><td><italic>D. iridis</italic> lariat capping ribozyme, RNA-puzzles submission model #1 (2012), MCM refined regions<xref ref-type="table-fn" rid="tblfn9">#</xref></td><td>69</td><td>&#8211;</td><td>&#8211;</td><td>17.0</td><td>&#8211;</td><td>&#8211;</td><td>50.0</td><td>62.5</td><td>46.2</td><td>38.5</td></tr><tr><td>HoxA9 5&#8242;-UTR 957&#8211;1132 domain, pseudoknot</td><td>176</td><td>15,580</td><td>12</td><td>&#8211;</td><td>19.5</td><td>20</td><td>41.7</td><td>&#8211;</td><td>50.0</td><td>&#8211;</td></tr><tr><td>HoxA9 5&#8242;-UTR 957&#8211;1132 domain, no pseudoknot</td><td>176</td><td>11,234</td><td>8</td><td>&#8211;</td><td>19.8</td><td>21</td><td>33.3</td><td>&#8211;</td><td>22.2</td><td>&#8211;</td></tr></tbody></table><table-wrap-foot><fn id="tblfn5"><label>*</label><p>Constraints were considered satisfied if the O2&#8242; of the 5&#8242;-residue was less than 30 &#197; from the C4&#8242; of the 3&#8242;-residue (<xref ref-type="supplementary-material" rid="SD2-data">Supplementary file 2</xref>).</p></fn><fn id="tblfn6"><label>&#8224;</label><p>For ligand-free states of the adenosylcobalamin riboswitch aptamer, cyclic-di-GMP riboswitch aptamer, and glycine riboswitch ligand-binding domain, RMSDs and percent constraints satisfied were calculated for gold-standard crystal structures solved in the presence of ligand.</p></fn><fn id="tblfn7"><label>&#8225;</label><p>For states not expected to agree with crystal structures, RMSD accuracy is given in parentheses.</p></fn><fn id="tblfn8"><label>&#167;</label><p>No strong constraints were selected for the unbound state of the glycine riboswitch ligand-binding domain without leader sequence.</p></fn><fn id="tblfn9"><label>#</label><p>Three separate modeling runs were performed for each ligand-binding state of the riboswitch aptamer, using distinct sets of prebuilt fragments prepared for RNA-puzzle 6; see &#8216;Materials and methods&#8217;. The number of models, size of largest cluster, cluster center RMSD (accuracy), and constraint satisfaction percentages are representative data from the modeling run with the most models generated. The intra-cluster RMSD used to estimate the in situ RMSD is calculated as the mean pairwise RMSD between the cluster centers of the top cluster from each of the three modeling runs.</p></fn><fn id="tblfn10"><label>&#182;</label><p>Calculated over refined regions or core domain residues after alignment using MAMMOTH; (<xref ref-type="bibr" rid="bib54">Ortiz et al., 2002</xref>) see &#8216;Materials and methods&#8217;.</p></fn><fn><p>MCM: multidimensional chemical mapping; RMSD: root-mean-squared-deviation.</p></fn></table-wrap-foot></table-wrap>